Skip to content
10-Q

Quarterly Report

Apimeds Pharmaceuticals US, Inc. APUS

0001213900-25-109280

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 12, 2025 12.58M sh
Shares Diluted Q3 2025 · Sep 30, 2025 12.58M sh
Shares Diluted Q3 2025 · Sep 30, 2025 10.31M sh
Shares Diluted Q3 2025 · Sep 30, 2024 7.9M sh
Shares Diluted Q3 2025 · Sep 30, 2024 7.9M sh
Capex Q3 2025 · Sep 30, 2025 $35.91K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$5.11M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$633.91K
Cash And Equivalents Q3 2025 · Sep 30, 2025 $6.99M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $3.46K
Stockholders Equity Q3 2025 · Sep 30, 2025 $8.16M
Stockholders Equity Q3 2025 · Jun 30, 2025 $9.74M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$1.76M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$1.36M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$1.05M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$713.97K
Stockholders Equity Q3 2025 · Mar 31, 2024 −$264.6K
Stockholders Equity Q3 2025 · Dec 31, 2023 $31.87K
Current Liabilities Q3 2025 · Sep 30, 2025 $1.09M
Current Liabilities Q3 2025 · Dec 31, 2024 $1.02M
Total Liabilities Q3 2025 · Sep 30, 2025 $1.09M
Total Liabilities Q3 2025 · Dec 31, 2024 $1.37M
Current Assets Q3 2025 · Sep 30, 2025 $9.09M
Current Assets Q3 2025 · Dec 31, 2024 $13.06K
Total Assets Q3 2025 · Sep 30, 2025 $9.25M
Total Assets Q3 2025 · Dec 31, 2024 $13.06K
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.14
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.47
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.04
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.14
Eps Basic Q3 2025 · Sep 30, 2025 −$0.14
Eps Basic Q3 2025 · Sep 30, 2025 −$0.47
Eps Basic Q3 2025 · Sep 30, 2024 −$0.04
Eps Basic Q3 2025 · Sep 30, 2024 −$0.14
Sga Expense Q3 2025 · Sep 30, 2025 $1.22M
Sga Expense Q3 2025 · Sep 30, 2025 $3.6M
Sga Expense Q3 2025 · Sep 30, 2024 $300K
Sga Expense Q3 2025 · Sep 30, 2024 $999.48K
Rd Expense Q3 2025 · Sep 30, 2025 $619.69K
Rd Expense Q3 2025 · Sep 30, 2025 $1.27M
Net Income Q3 2025 · Sep 30, 2025 −$1.78M
Net Income Q3 2025 · Sep 30, 2025 −$4.85M
Net Income Q3 2025 · Jun 30, 2025 −$2.66M
Net Income Q3 2025 · Mar 31, 2025 −$402.4K
Net Income Q3 2025 · Sep 30, 2024 −$332.52K
Net Income Q3 2025 · Sep 30, 2024 −$1.08M
Net Income Q3 2025 · Jun 30, 2024 −$449.36K
Net Income Q3 2025 · Mar 31, 2024 −$296.47K
Operating Income Q3 2025 · Sep 30, 2025 −$1.84M
Operating Income Q3 2025 · Sep 30, 2025 −$4.87M
Operating Income Q3 2025 · Sep 30, 2024 −$300K
Operating Income Q3 2025 · Sep 30, 2024 −$999.48K